COMPASS PATHWAYS
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. It is conducting a large-scale psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North America. It was founded in 2016 and is based in Altrincham, Cheshire.
COMPASS PATHWAYS
Industry:
Biotechnology Health Care Life Science Personal Health Wellness
Founded:
2016-06-13
Address:
Altrincham, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.compasspathways.com
Total Employee:
11+
Status:
Active
Total Funding:
116.21 M USD
Technology used in webpage:
Google Font API Amazon IPv6 COVID-19 Apple Mobile Web App Capable Amazon Virginia Region Amazon S3 CDN Amazon CloudFront Java EE New Relic
Similar Organizations
Calibrate
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
Libre Foods
Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet and animals.
LifeLens Technologies
LifeLens Technology is a biotechnology company that leads in innovative next generation treatment devices for personal health monitoring.
Mindfule
The Foodcare Company dedicated to improving brain and gut health through smart nutrition solutions.
Testmate Health
Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.
SilverCloud Health
SilverCloud Health provides immediate access to evidence-based and supported digital therapies.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series B - COMPASS Pathways
Camden Partners
Camden Partners investment in Series B - COMPASS Pathways
Soleus Capital
Soleus Capital investment in Series B - COMPASS Pathways
McQuade Center for Strategic Research and Development
McQuade Center for Strategic Research and Development investment in Series B - COMPASS Pathways
Founders Fund
Founders Fund investment in Series B - COMPASS Pathways
Justin Mateen
Justin Mateen investment in Series B - COMPASS Pathways
ATAI Life Sciences
ATAI Life Sciences investment in Series B - COMPASS Pathways
Able Partners
Able Partners investment in Series B - COMPASS Pathways
Skyviews Life Science
Skyviews Life Science investment in Series B - COMPASS Pathways
WPSS.bio
WPSS.bio investment in Convertible Note - COMPASS Pathways
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-20 | COMPASS Pathways appoints Kebir Nath as chief executive |
| 2020-09-15 | Compass Pathways set to become the first psychedelic biotech IPO |
Official Site Inspections
http://www.compasspathways.com Semrush global rank: 500.13 K Semrush visits lastest month: 99.51 K
- Host name: 213.171.208.113
- IP address: 213.171.208.113
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "COMPASS Pathways"
About Compass Pathways | Our Values & Mental Health Innovations
Jul 31, 2024 Compassion Everything we do is rooted in compassion. We care deeply about reducing people’s suffering, and we harness that passion to drive our work forward. Boldness …See details»
Compass Pathways - Investor Relations
We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who …See details»
Compass Pathways - Wikipedia
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), is currently in phase 3 clinical trials for treatment-resistant depression. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MD…See details»
Executive Team - Compass Pathways
News and views. News and views. Our collective understanding of mental illness is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital …See details»
Compass Pathways - Compass Pathways Announces Fourth …
Dec 31, 2024 LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»
Compass Pathways - Compass Pathways Announces Third Quarter …
Oct 31, 2024 LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence …See details»
COMPASS Pathways - Crunchbase Company Profile & Funding
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing …See details»
Compass Pathways Announces Fourth Quarter and Full-Year 2024 …
LONDON & NEW YORK, February 27, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»
COMPASS Pathways
2 days ago We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.See details»
Partnerships - Compass Pathways
NAMI (National Alliance on Mental Illness) is the nation’s largest grassroots mental health organization dedicated to improving the lives of individuals affected by mental illness. They …See details»
COMPASS Pathways plc (CMPS)
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials …See details»
Compass Pathways - News & events - Events & presentations
Feb 27, 2025 [email protected]. Follow us. follow us on LinkedIn; follow us on Youtube; follow us on X; Quick links. SEC Filings opens in new window. FAQs opens in new …See details»
Compass Pathways Announces Publication of Results from
5 days ago Forward-looking statements include express or implied statements relating to, among other things, statements regarding our business strategy and goals; our plans and …See details»
COMPASS Pathways
Contact: [email protected] Over 70% of patients in early studies rank psilocybin therapy among the top five most meaningful experiences of their lives. ... 1Statistics from …See details»
Compass Pathways Announces Publication of Results from …
5 days ago Media: Media, [email protected] Investors: Stephen Schultz, [email protected] , +1 401 290 7324 News Provided by Business Wire …See details»
Compass Pathways Announces Pricing of Underwritten Offering
LONDON & NEW YORK, January 10, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»
Mental Health Careers and Jobs | Compass Pathways
Jul 15, 2024 Join us. Join us. We are united by our commitment to improving mental health. Join us. Our culture; Diversity, equity and inclusion; Benefits; Careers; 60 seconds with ...See details»
Compasspathways.com - YourDigitalRights.org
Compasspathways.com. Delete your compasspathways.com account or request your data. ... Optionally provide any additional information which will help the organization to locate your …See details»
Compass Pathways - News & events - News
[email protected]. Follow us. follow us on LinkedIn; follow us on Youtube; follow us on X; Quick links. SEC Filings opens in new window. FAQs opens in new window. Investor email …See details»
Compass Pathways Announces Pricing of Underwritten Offering
Jan 10, 2025 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced …See details»